Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia

Infection and Immunity

Volumn 69, Issue 6, 2001, Pages 3569-3575

  Alcantara, R B ^a   Preheim, L C ^a   Gentry Nielsen, M J ^a  

^a VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3; OPSONIN; PNEUMOLYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; CIRCULATION; COMPLEMENT DEFICIENCY; COMPLEMENT HEMOLYSIS TEST; CONTROLLED STUDY; CORRELATION FUNCTION; LIVER CIRRHOSIS; MALE; NONHUMAN; OPSONIZATION; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BACTEREMIA; BACTERIAL PROTEINS; CARBON TETRACHLORIDE; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; LIVER CIRRHOSIS, ALCOHOLIC; MALE; PHAGOCYTOSIS; PNEUMOCOCCAL INFECTIONS; RATS; RATS, SPRAGUE-DAWLEY; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS;

EID: 0035024478     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.6.3569-3575.2001     Document Type: Article

References (31)

1. Infections in the alcoholic
2. Role of pneumolysin's complement-activating activity, during pneumococcal bacteremia in cirrhotic rats
3. The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model
4. Localization of complement component 3 on Streptococcus pneumoniae: Anti-capsular antibody causes complement deposition on the pneumococcal capsule
5. The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream
6. Mechanisms of host defense against infection with Streptococcus pneumoniae
7. Immunological studies in pneumococcal disease
8. Phagocytosis of Streptococcus pneumoniae measures in vitro and in vivo in a rat model of carbon tetrachloride-induced liver cirrhosis
9. The role of opsonins in recovery from experimental pneumococcal pneumonia
10. Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality
11. The critical role of complement in experimental pneumococcal sepsis
12. Opsonic and nonopsonic interactions of C3 with Streptococcus pneumoniae
13. Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1β by human mononuclear phagocytes
14. Invasive pneumococcal disease in the immunocompromised host
15. Effects of pneumolysin on human polymorphonuclear leukocytes and platelets
16. Confirmation of the role of pneumolysin in ocular infections with Streptococcus pneumoniae
17. Growth and virulence of a complement-activation-negative mutant of Streptococcus pneumoniae in the rabbit cornea
18. Pneumococcal bacteremia - No change in mortality in 30 years: Analysis of 104 cases and review of the literature
19. Pneumococcal bactereamia during a recent decade
20. Pneumococcal pneumonia in a rat model of cirrhosis: Effects of cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae
21. Biological properties of pneumolysin
22. Activation of human complement by the pneumococcal toxin pneumolysin
23. High yield micronodular cirrhosis in the rat
24. Pneumolysin: A multifunctional pneumococcal virulence factor
25. Toxicity of pneumolysin to pulmonary alveolar epithelial cells
26. Pneumolysin activates phospholipase A in pulmonary artery endothelial cells
27. Alcoholism, infection and altered host defenses: A review of clinical and experimental observations
28. Complement and the host's defense against the pneumococcus
29. The role of C3 as an opsonin in the early stages of infection
30. Bacterial infections complicating liver disease